Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetragarapharma.com
Twitter@TragaraPharma
CategoryBioTech
Phone(858) 350-6900
Emailcmiller@tragaraph...
Employees
Description pharmaceutical

Offices

HQ
10955 Vista Sorrento Parkway, Suite 120
San Diego, CA, 92130
USA

People

Board of Directors
Board of Directors

Investments

S*Bio 1/2009

Funding

TOTAL $5M
FUNDING TOTAL $5M
Series B, 4/2010
Domain Associates
Mitsubishi Motors
Morgenthaler Ventures
Oxford Bioscience Partners
ProQuest Investments
$5M
DEBT TOTAL $4M
Debt, 8/2012
$4M

Tags

Tragara

Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of various cancers. Tragara launched operations in January 2007 and is focusing its development resources on two proprietary compounds: (1) Capoxigem® (apricoxib; TG01), an oral, potent, and selective inhibitor of cyclooxygenase-2 (COX-2) for the treatment of solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer and (2) TG02- multikinase inhibitor for the treatment of hematologic and solid tumors.

Recent Milestones

Videos

Screenshots

Tragara screenshot
Above: Tragara Screenshot -- #1
Uploaded: 6/13/09

Sources

  1. S*Bio, Tragara forge $112M development pact (fiercebiotech.com) [edit]
  2. Tragara Pharmaceuticals, Inc.: Series B $5M (onbiovc.com) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 2/11/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy